PMI-CPMAI places strong emphasis on responsible and compliant AI, especially in domains like healthcare, where data is highly sensitive and regulations are strict and multi-jurisdictional. When AI systems must interoperate with existing healthcare databases containing patient information, the project manager must ensure that data use, access, storage, and sharing comply with privacy, consent, security, and cross-border transfer requirements.

A Privacy Impact Assessment (PIA) (often aligned with or equivalent to a Data Protection Impact Assessment) is highlighted as a critical step in such scenarios. It systematically identifies how personal data will be processed, maps data flows, evaluates risks to individuals’ privacy, and determines whether the AI solution complies with applicable laws (e.g., GDPR-like regimes, health data regulations, and medical confidentiality obligations). It also guides the design of safeguards such as data minimization, access controls, anonymization/pseudonymization, and audit trails.

While prediction accuracy, financial risk analysis, and regulatory reports are important, PMI-CPMAI frames PIAs as a foundational risk and governance control whenever AI operates on sensitive data across multiple legal contexts. Without a properly performed privacy impact assessment, the project would be exposed to legal non-compliance, ethical breaches, and loss of trust, regardless of how accurate or cost-effective the model might be. Therefore, implementing privacy impact assessments is the critical step that must be performed.